Nextgen Star News Today

/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce the launch of its...

“Scientists and clinicians in the early phases of their career are crucial to our mission to end cancer and play a central role in driving innovation in all areas of cancer research, prevention, diagnosis and treatment,” said Giulio Draetta, M.D., Ph.D., chief scientific officer at MD Anderson. “We congratulate these junior investigators on receiving such notable recognition from AACR for their high-impact work.” Navin: Outstanding Achievement in Basic Cancer Research This prestigious A...